Antiviral treatment is associated with improved hearing outcomes in neonates presenting with cCMV and symptomatic central nervous system involvement.

Antiviral treatment is associated with improved hearing outcomes in neonates presenting with cCMV and symptomatic central nervous system involvement.
Adherence to meeting EHDI 1-3-6 diagnostic and intervention guidelines has a compelling effect on pediatric language development based on recent literature.
Septoplasty should be performed in patients with functional problems related to congenital anomalies or trauma.
Current retrospective studies and meta-analyses support the thesis that SGP improves PSG measures in children with congenital laryngomalacia and sleep dependent laryngomalacia.
Multiple therapeutic options may be effective for treating mild pediatric OSA including observation, management with anti-inflammatory medications, and surgery.
Patients with EVA are commonly discouraged from playing contact sports due to concerns about a possible risk for sudden hearing drops or vestibular dysfunction following even minor head trauma.
Botulinum toxin injection may be ideal, especially for patients who are candidates for injections under local anesthesia.
Injection medialization with a temporary injectable can improve symptoms of hoarseness, dysphonia, feeding difficulties, and aspiration in pediatric patients with unilateral VFI.
Given the current evidence available, it is recommended that infants who fail their newborn hearing screening should undergo CMV testing.
Does age directly mediate the perforation closure, hearing, or complication outcomes after tympanic membrane perforation repair in pediatric patients?